Pharmacology Exam 2 Flashcards
Liraglutide: Indication and distribution
Primarily - DM2
Also used as an anorexiant
highly bound to protein
Anorexiant MOA
Sympathomimetic amines → stimulate the satiety centers in the hypothalamus and limbic regions
- noradrenergic, dopaminergic, or serotonergic pathways
Anorexiants: Contraindications
- General
- Liraglutide
- Lorcaserin
DM - can cause hypoglycemia
Liraglutide - Pregnancy: due to wt loss
Lorcaserin -
- Pregnancy due to category X
- other drugs that increase serotonin
- <18 yo
Anorexiants: ADRs
- General
Hypoglycemia - decreaed intake
CNS overstimulation and agitation, confusion, insomnia, dizziness, hypertension, headache, palpitations, arrhythmias, dry mouth, mydriasis, dysuria, constipation, vomiting, diarrhea, and impotence
ADRs
Liraglutide
N/V/D
- Hypoglycemia
- Suicidal Ideation
- Slowed gastric emptying – may alter other drug’s absorption
ADRs
Lorcaserin
Suicidal ideation
stimulate ADRs
euphoria/hallucinations
priapism/prolactin
CBC changes
hypoglycemia
Anticonvulsants (AEDs): Precautions
- Increased risk for suicidal thoughts
- Monitor seizure activity
- associated with fetal defects
- suicidal ideation
- lactation
Anticonvulsants: Topiramate MOA
Inhibition of carbonic anhydrase → may lead to increased renal bicarb LOSS → metabolic acidosis
Inhibition of carbonic anhydrase can also lead to increased ammonia levels
Phenytoin (Hydantoin)
- MOA
- Blackbox Warning
- Common Hypersensitivity
- Newborn who have been exposed
- blocks Na+ - decreased potential
- IV < 50mg/min in adults and 1-3mg/kg in peds
- Phenytoin-induced hepatitis is a common hypersensitivity
- Newborns need Vit K
Phenytoin (Hydantoin): Common Drug Interaction
IBUPROFEN – increases dilantin lvls
Phenytoin monitoring
LFTs,CBC with diff, UA
Drug levels
Assess for phenytoin hypersensitivity syndrome → fever, rash, lymphadenopathy → typically weeks 3-8
Phenytoin (Hydantoin): Education
Good oral hygiene – tenderness
Urine may look pink, red, or reddish brown
DM - inhibits glucose stimulated insulin release - hyperglycemia
Phenytoin indication
Seizures, status epilepticus
Carbamazepine indications
epilepsy, bipolar disorder, trigeminal neuralgia, aggressive behavior
Carbamazepine: MOA - including additional
Decreases the amount of Na+ going into cortical neurons → decreases action potential → decreased seizure activity from interrupting the abnormal neuronal discharge
Alos: anticholinergic, antidiuretic, antidysrhythmic, and antidepressant activity
Carbamazepine: Metabolism
Self-induced – therapeutic ranges may fall
Carbamazepine: Precautions
-include Black Box Warning
Intraoccular pressure – due to anticholinergic affects
grapefruit juice increases drug levels
Decrease TSH
Black Box Warning: SJS - Screen asian patients for HLA-B*1202 gene
Black Box Warning: May cause blood dyskrasias – leukopenia, thrombocytopenia, agranulocytosis, and aplastic anemia
Carbamazepine: screening
SJS and toxic epidermal necrolysis → particularly among asians
Screen asian patients for HLA-B*1202 gene
Carbamazepine: Contraindications
pregnancy: CATEGORY D
Hypersensitivity to Carbamazpines or TCAs,
hx of bone marrow suppression,
concurrent administration with MAOs
Carbamazepine can decrease levels of the following drugs:
Beta blockers, warfarin
Carbamazepine: Monitor
Baseline CBC, chemistry, LFT, Renal function, CMP, TSH/ T4 → then frequently → then every 3-4 mo if nrml
Carbamazepine → drug levels
Lamotrigine: Indications
seizure, bipolar disorder, mood
Lamotrigine: MOA
decraese sodium channels and inhibits the presynaptic release of glutamate and aspartate in the neuron
Carbamazepine: Side Effects
N/V, dizzy, drowsy, DRY MOUTH, feels like swollen tongue